|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
activity in mice with cardiac-restricted expression of Tumor Necrosis Factor: potential role of TGF
/Smad3
1 Medicine, Baylor College of Medicine, Houston, Texas, United States
2 Medicine, Baylor College of Medicine, Houston, United States
* To whom correspondence should be addressed. E-mail: pbarger{at}bcm.edu.
A shift in energy substrate utilization from fatty acids to glucose has been reported in failing hearts, resulting in improved oxygen efficiency, yet perhaps also contributing to a state of energy deficiency. PPAR
, the principal transcriptional regulator of cardiac fatty acid
-oxidation (FAO) genes, is down regulated in heart failure and this may contribute to reduced fatty acid utilization. Cardiomyopathic states are also accompanied by elevated levels of circulating cytokines, such as tumor necrosis factor (TNF), as well as increased local production of cytokines and pro-fibrotic factors, such as TGF
. However, whether these molecular pathways directly modulate cardiac energy metabolism and PPAR
activity is not known. Therefore, FAO capacity and FAO gene expression were determined in mice with cardiac-restricted over expression of TNF (MHCsTNF3). MHCsTNF3 hearts had significantly lower FAO capacity and decreased expression of PPAR
and FAO target genes compared to control hearts. Surprisingly, TNF had little effect on PPAR
activity and FAO rates in cultured ventricular myocytes, suggesting that TNF acts indirectly on myocyte FAO in vivo. We found that TGF
expression was upregulated in MHCsTNF3 hearts and that treatment of cultured myocytes with TGF
significantly suppressed FAO rates and directly impaired PPAR
activity, a result reproduced by Smad3 over expression. This work demonstrates that TGF
signaling pathways directly suppress PPAR
activity and reduce FAO in cardiac myocytes, perhaps in response to locally elevated TNF. Although speculative, TGF
driven repair mechanisms may also include the additional benefit of limiting FAO in injured myocardium.
This article has been cited by other articles:
![]() |
C. Pellieux, C. Montessuit, I. Papageorgiou, and R. Lerch Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-{alpha} Cardiovasc Res, May 1, 2009; 82(2): 341 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. LeBrasseur, T.-A. S. Duhaney, D. S. De Silva, L. Cui, P. C. Ip, L. Joseph, and F. Sam Effects of Fenofibrate on Cardiac Remodeling in Aldosterone-Induced Hypertension Hypertension, September 1, 2007; 50(3): 489 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Remels, P. Schrauwen, R. Broekhuizen, J. Willems, S. Kersten, H. R. Gosker, and A. M. Schols Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD Eur. Respir. J., August 1, 2007; 30(2): 245 - 252. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |